Cargando…

Arrhythmic Burden and Outcomes in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a devastating, life-limiting disease driven by small vessel vascular remodeling leading to a rise in pulmonary vascular resistance (PVR). Patients present with a range of symptoms including shortness of breath, exercise intolerance, palpitations or syncope. S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Middleton, Jennifer T., Maulik, Angshuman, Lewis, Robert, Kiely, David G., Toshner, Mark, Charalampopoulos, Athanasios, Kyriacou, Andreas, Rothman, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664000/ https://www.ncbi.nlm.nih.gov/pubmed/31396515 http://dx.doi.org/10.3389/fmed.2019.00169

Ejemplares similares

Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease
por: Charalampopoulos, Athanasios, et al.
Publicado: (2018)

Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
por: Alandejani, Faisal, et al.
Publicado: (2022)

Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I
por: Billings, Catherine G., et al.
Publicado: (2018)

Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
por: Lewis, Robert A., et al.
Publicado: (2020)

Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension
por: Lewis, Robert A., et al.
Publicado: (2021)

Repurposing of medications for pulmonary arterial hypertension
por: Toshner, Mark, et al.
Publicado: (2020)

Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy
por: Wilkins, Martin R., et al.
Publicado: (2021)

CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension
por: Shahin, Yousef, et al.
Publicado: (2022)

Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets
por: Saadeh, Khalil, et al.
Publicado: (2021)

Clinical profile and arrhythmic burden in MINOCA
por: Lypovetska, S
Publicado: (2023)

Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction
por: Garg, Pankaj, et al.
Publicado: (2021)

Arrhythmic Burden of Adult Survivors With Repaired Total Anomalous Pulmonary Venous Connection
por: Touray, Mariama, et al.
Publicado: (2022)

Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension
por: Sun, Wei, et al.
Publicado: (2018)

Management of the arrhythmic manifestations of cardiac sarcoidosis
por: Cherrett, Callum, et al.
Publicado: (2023)

Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension
por: Lewis, Robert A., et al.
Publicado: (2020)

Inflammasome Activation in Pulmonary Arterial Hypertension
por: Foley, Anna, et al.
Publicado: (2022)

Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension
por: Rothman, Alexander M.K., et al.
Publicado: (2015)

Editorial: Pulmonary Hypertension: Mechanisms and Management, History and Future
por: Thompson, A. A. Roger, et al.
Publicado: (2020)

Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?
por: Sofianopoulou, Eleni, et al.
Publicado: (2020)

Myocardial fibrosis and arrhythmic burden in systemic sclerosis
por: Ross, Laura, et al.
Publicado: (2022)

Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension
por: Goddard, Julia C, et al.
Publicado: (2017)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Screening strategies for pulmonary arterial hypertension
por: Kiely, David G, et al.
Publicado: (2019)

The burden of comorbidities in pulmonary arterial hypertension
por: Lang, Irene M, et al.
Publicado: (2019)

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
por: Chin, Matthew, et al.
Publicado: (2018)

Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling
por: Andre, Patrick, et al.
Publicado: (2022)

Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension
por: Alabed, Samer, et al.
Publicado: (2023)

The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
por: Taylor, Shalina, et al.
Publicado: (2018)

Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension
por: Pan, Irene Z., et al.
Publicado: (2020)

Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
por: Bauchmuller, Kris, et al.
Publicado: (2021)

Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension
por: Wardle, Mikaela, et al.
Publicado: (2022)

Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI
por: Johns, Christopher S., et al.
Publicado: (2018)

OUTPATIENT CARDIAC MONITORING TO DETERMINE ARRHYTHMIC BURDEN AFTER COVID-19 HOSPITALIZATION
por: Beccarino, Nicholas, et al.
Publicado: (2022)

Hospital burden of pulmonary arterial hypertension in France
por: Bergot, Emmanuel, et al.
Publicado: (2019)

The economic burden of pulmonary arterial hypertension in Spain
por: Zozaya, Néboa, et al.
Publicado: (2022)

Critical care outcome of pulmonary artery hypertension
por: Philips, A, et al.
Publicado: (2011)

Chronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatment
por: Toshner*, Mark, et al.
Publicado: (2014)

A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension
por: Bunclark, Katherine, et al.
Publicado: (2021)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis
por: Tuhy, Tijana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8p39k4u0el40g9le2sr1vpc57j